GLIVEC 100 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVDC aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930187210
  • CIP7 3018721
  • CIS 64936439
  • Registration number EU/1/01/198

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
IMATINIB BASE, IMATINIB (MÉSILATE D')
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVDC aluminium de 60 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE ; prescription réservée aux spécialistes et services CANCEROLOGIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription initiale hospitalière semestrielle ; prescription réservée aux spécialistes et services HEMATOLOGIE…
Marketing status
Déclaration de commercialisation
Authorised on
2003-11-11
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930187210
{
  "cis": "64936439",
  "cip7": "3018721",
  "form": "comprimé pelliculé",
  "name": "GLIVEC 100 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVDC aluminium de 60 comprimé(s)",
  "cip13": "3400930187210",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "308.81",
  "authorisedOn": "2003-11-11",
  "compositions": [
    {
      "name": "IMATINIB BASE",
      "nature": "FT",
      "strength": "100 mg",
      "linkageNumber": "1",
      "substanceCode": "60707",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "IMATINIB (MÉSILATE D')",
      "nature": "SA",
      "strength": "119,5 mg",
      "linkageNumber": "1",
      "substanceCode": "68227",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE ; prescription réservée aux spécialistes et services CANCEROLOGIE ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription initiale hospitalière semestrielle ; prescription réservée aux spécialistes et services HEMATOLOGIE ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "307.79",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "GLIVEC 100 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVDC aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2021-03-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "IMATINIB BASE",
    "IMATINIB (MÉSILATE D')"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEPATO/GASTRO-ENTEROLOGIE",
    "prescription réservée aux spécialistes et services CANCEROLOGIE",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription initiale hospitalière semestrielle",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/01/198",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930187210"